Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ischemic Heart Disease

  Free Subscription


Articles published in Br J Haematol

Retrieve available abstracts of 6 articles:
HTML format



Single Articles


    November 2021
  1. CHEN S, Chen D, Liu Y, Xu Y, et al
    Enhanced clot lysis by a single point mutation in a reteplase variant.
    Br J Haematol. 2021 Nov 16. doi: 10.1111/bjh.17942.
    PubMed     Abstract available


    October 2021
  2. YING L, Wang J, Li J, Teng J, et al
    Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on-treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)-2 Trial.
    Br J Haematol. 2021 Oct 5. doi: 10.1111/bjh.17847.
    PubMed     Abstract available


    September 2021
  3. TANG CPS, Lip GYH, McCormack T, Lyon AR, et al
    Management of cardiovascular complications of bruton tyrosine kinase inhibitors.
    Br J Haematol. 2021 Sep 8. doi: 10.1111/bjh.17788.
    PubMed    


    June 2021
  4. ALONSO-FERNANDEZ-GATTA M, Martin-Garcia A, Martin-Garcia AC, Lopez-Cadenas F, et al
    Predictors of cardiovascular events and all-cause of death in patients with transfusion-dependent myelodysplastic syndrome.
    Br J Haematol. 2021 Jun 28. doi: 10.1111/bjh.17652.
    PubMed     Abstract available


    August 2020
  5. CORNELL RF, Goldhaber SZ, Engelhardt BG, Moslehi J, et al
    Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents.
    Br J Haematol. 2020;190:555-561.
    PubMed     Abstract available


  6. PASTORI D, Lip GYH, Poli D, Antonucci E, et al
    Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study.
    Br J Haematol. 2020;190:588-593.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: